Coave Therapeutics
2 followers
‌
Coave Therapeutics develops innovative gene therapy products for rare ophthalmic diseases to preserve visual autonomy in affected patients.
Industries
Headquarters
Employees
Links
Org chart
Rodolphe Clerval
CEO & Director
Rodolphe Clerval
Collapse
Catherine Mathis
Chief Development Officer
Claudia Mitchell
Interim Chief Scientific Officer
Julien Berger
VP, Legal Affairs & Corporate Secretary
Gaelle Lefevre
Head, Discovery Sciences
Cédric Cousteix
Finance Director
Lolita Petit
Chief Scientific Officer
Marie-Anne Burlot
Preclinical Manager
Sandrine Meunier
Director Of Clinical Development At Eyedna Therapeutics A Subsidiary Of Coave Therapeutics
